“abiraterone” Archives

in
Entry Author Date Location
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More 02/01/19 National
Study: Blood Test for Prostate Cancer Can Guide Therapy, Extend Lives 07/02/18 San Diego
Bio Roundup: Lung Cancer Questions, Migraine Races, HIV Battle & More 02/09/18 National
Bio Roundup: Spark’s Road Ahead, Juno Rumors, Merck’s Big Day & More 01/19/18 National
OncoGenex Hires Advisor, Evaluates Options As Cancer Drug Fails Again 08/16/16 Seattle
Tokai Pharma Shutters Prostate Cancer Drug Trial Early, Shares Crumble 07/26/16 Boston
East Coast Biotech Roundup: Flagship, SQZ, Epizyme, IPOs & More 06/26/15 Boston
Cancer Immunotherapy Companies: Looking Forward and Looking Back 03/02/15 Seattle
End of Dendreon: Valeant’s $400M is Sole Offer, Purchase is Next 02/10/15 Seattle
Dendreon Gets $296M Bid From Valeant as Bankruptcy Auction Looms 01/30/15 Seattle
As Huge Bills Loom, Immunotherapy Pioneer Dendreon Enters Bankruptcy 11/10/14 Seattle
Tokai Bags $97M For Prostate Cancer Drug in Upsized IPO 09/17/14 Boston
West Coast Biotech Roundup: Gates, Orexigen, Medivation & More 09/12/14 Seattle
Exelixis Axes 70% of Workforce as Cancer Drug Flops, Shares Routed 09/02/14 San Francisco
East Coast Biotech Roundup: Amicus, Accelerator, Seventh Sense, & More 08/15/14 Boston
Tokai, Chasing the Field in Prostate Cancer, Files For IPO 08/12/14 Boston
With J&J Deals, Aduro’s Cancer Vaccines Have New Chance To Prove Worth 06/18/14 San Francisco
OncoGenex Retrenches, and Searches for Answers, After Failed Trial 05/22/14 Seattle
OncoGenex’s Long Wait For Cancer Drug Ends With a Phase 3 Stumble 04/28/14 Seattle
Tokai Looks to Follow Fast Behind J&J, Medivation in Prostate Cancer 02/13/13 Boston
Dendreon Cutting 600 Jobs, Closing NJ Plant As Sales Fall Short 07/30/12 Seattle
Emerging Challenges of Prostate Cancer Drug Development 06/06/12 National
J&J Prostate Cancer Trial Shouldn’t Have Been Stopped Early 06/03/12 National
Page 1 of 1